SCHEMBL29108596

SCHEMBL29108596

CCCCC#Cc1nc(N)c2nc[nH]c2n1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 9/20 0.49
▸ ADORA2A P29274 10/20 0.44
▸ ADORA2B P29275 4/20 0.44
▸ ADORA1 P30542 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ PMP22 Q01453 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16585684 0.96 ADORA3 (0.48) ADORA3ADORA2AADORA2BADORA1
SCHEMBL15253136 0.95 ADORA2A (0.47) ADORA3ADORA2AADORA2BADORA1
SCHEMBL29108561 0.83 ADORA3 (0.52) ADORA3ADORA2AADORA2BADORA1CYP2C9
SCHEMBL14375141 0.78 ADORA3 (0.37) ADORA3ADORA2AADORA1
SCHEMBL26968336 0.77 ADORA3 (0.64) ADORA3ADORA2AADORA2BADORA1
SCHEMBL26968745 0.75 ADORA3 (0.46) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL29108609 0.75 ADORA3 (0.38) ADORA3ADORA2AADORA2BADORA1
SCHEMBL16585685 0.75 ADORA3 (0.61) ADORA3ADORA2AADORA2BADORA1
SCHEMBL15253137 0.74 ADORA3 (0.60) ADORA3ADORA2AADORA2BADORA1
SCHEMBL26968662 0.73 ADORA3 (0.45) ADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117083286-A Pair A 2A A is a 3 Adenosine derivatives having antagonism to adenosine receptor and process for preparing same 未来制药有限公司 2023-11-17 — — CN disclosed
Send feedback